Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-02 @ 6:11 PM
Study NCT ID:
NCT02130635
Status:
COMPLETED
Last Update Posted:
2018-10-11
First Post:
2014-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-01
First Submit QC Date:
None
Study First Post Date:
2014-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-10
Results First Submit QC Date:
None
Results First Post Date:
2017-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-11
Last Update Post Date:
2018-10-11
Last Update Post Date Type:
ACTUAL